|
|
Vol. 14.44 – 9 November, 2023
|
|
|
|
|
|
|
|
Using genetically engineered mouse models, patient-derived xenografts, and patient samples investigators found inhibition of KRAS promoted transition to a quiescent AT1-like cancer cell state in lung adenocarcinoma tumors. [Cancer Discovery]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Researchers analysed fibroblast growth factor 10 signaling in human lung sections and isolated cells from healthy donor, smoker, and COPD lungs. [European Respiratory Journal]
|
|
|
|
|
|
Scientists exploited tissue-optimized ribosome profiling and severe-COVID-19 model mice to establish the first temporal translation profiles of virus and host genes in the lungs during SARS-CoV-2 pathogenesis. [Experimental & Molecular Medicine]
|
|
|
|
|
|
Using co-cultures of patient-derived mesothelioma cell lines and lung fibroblasts, investigators demonstrated that fibroblast activation was a self-propagated process producing a fibrotic extracellular matrix and triggering drug resistance in mesothelioma cells.
[Cell Death & Differentiation]
|
|
|
|
|
|
The authors employed a 3D biomimetic microfluidic lung-on-chip platform and RNA-sequencing to examine the effects of two model anthropogenic engineered nanoparticles.
[Environmental Science & Technology]
|
|
|
|
|
|
|
|
Molecular modeling, in vitro binding, and site-directed mutagenesis were used to identify the copper metabolism gene MURR1 domain (COMMD) 4-H2B binding pose and develop a H2B peptide to inhibit the COMMD4-H2B interaction. [British Journal of Cancer]
|
|
|
|
|
|
The authors tudied the mechanisms of resistance to glucose metabolism-targeting treatments, and found that glucose restriction in lung adenocarcinoma and other tumors induced cancer cell de-differentiation, leading to a more aggressive phenotype.
[Cancer Research]
|
|
|
|
|
|
Combining high-mass-resolution imaging mass spectrometry with consensus clustering, four tumor- and four stroma-specific subtypes with distinct metabolite patterns were identified in 330 lung squamous cell carcinoma patients.
[npj Precision Oncology]
|
|
|
|
|
|
Scientists found that in lung cancer cells, the expression of CNOT3 could be regulated by epidermal growth factor receptor (EGFR) signaling pathway and c-Jun transcriptionally regulated its expression. [Cell Death Discovery]
|
|
|
|
|
|
|
|
The authors investigate processes such as cellular pyroptosis, examine the intricate crosstalk between bone morphogenetic protein receptor type 2 mutations and the immune response, and shed light on key signaling pathways involved in the inflammatory response in the context of pulmonary hypertension. [Journal Of Advanced Research]
|
|
|
|
|
|
|
|
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) granted conditional marketing authorization approval for KRAZATI® as a monotherapy indicated for the treatment of adult patients with advanced NSCLC with KRASG12C mutation, under specific circumstances. [Mirati Therapeutics, Inc.]
|
|
|
|
|
|
|
|
December 2 – 6, 2023 Boston, Massachusetts, United States
|
|
|
|
|
|
|
|
|
|
|
University of Cambridge – Cambridge, England, United Kingdom
|
|
|
|
|
|
|
Temple University – Philadelphia, Pennsylvania, United States
|
|
|
|
|
|
|
National Jewish Health – Denver, Colorado, United States
|
|
|
|
|
|
|
Cedars-Sinai – Los Angeles, California, United States
|
|
|
|
|
|
|
University of Alabama at Birmingham – Birmingham, Alabama, United States
|
|
|
|
|
|